摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,14-dibromo-N'-ethoxycarbonyltetrandrine | 1400913-98-5

中文名称
——
中文别名
——
英文名称
5,14-dibromo-N'-ethoxycarbonyltetrandrine
英文别名
ethyl (1S,14S)-11,19-dibromo-9,20,21,25-tetramethoxy-15-methyl-7,23-dioxa-15,30-diazaheptacyclo[22.6.2.23,6.18,12.114,18.027,31.022,33]hexatriaconta-3(36),4,6(35),8,10,12(34),18(33),19,21,24,26,31-dodecaene-30-carboxylate
5,14-dibromo-N'-ethoxycarbonyltetrandrine化学式
CAS
1400913-98-5
化学式
C40H42Br2N2O8
mdl
——
分子量
838.59
InChiKey
KRNDBRKGTJCIIK-KYJUHHDHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    8.3
  • 重原子数:
    52
  • 可旋转键数:
    6
  • 环数:
    8.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    88.2
  • 氢给体数:
    0
  • 氢受体数:
    9

反应信息

  • 作为产物:
    描述:
    5,14-dibromo-7-methoxy fangchinoline 、 氯甲酸乙酯甲苯 为溶剂, 反应 4.0h, 以37%的产率得到5,14-dibromo-N'-ethoxycarbonyltetrandrine
    参考文献:
    名称:
    Partial synthesis and biological evaluation of bisbenzylisoquinoline alkaloids derivatives: potential modulators of multidrug resistance in cancer
    摘要:
    A series of new bisbenzylisoquinoline alkaloids was partially synthesized from tetrandrine and fangchinoline and evaluated for their ability to reverse P-glycoprotein-mediated multidrug resistance (MDR) in cancer cells. All the test compounds increased the intracellular accumulation rate of rhodamine 123 in MDR cells (Bel7402 and HCT8), and most exhibited more potent MDR-reversing activity relative to the reference compound verapamil. Compounds 8, 10, 13, and 14 enhanced intracellular accumulation of doxorubicin in Bel7402 and HCT8 cells.
    DOI:
    10.1080/10286020.2012.680443
点击查看最新优质反应信息

文献信息

  • Partial synthesis and biological evaluation of bisbenzylisoquinoline alkaloids derivatives: potential modulators of multidrug resistance in cancer
    作者:Ping He、Hua Sun、Xi-Xian Jian、Qiao-Hong Chen、Dong-Lin Chen、Geng-Tao Liu、Feng-Peng Wang
    DOI:10.1080/10286020.2012.680443
    日期:2012.6
    A series of new bisbenzylisoquinoline alkaloids was partially synthesized from tetrandrine and fangchinoline and evaluated for their ability to reverse P-glycoprotein-mediated multidrug resistance (MDR) in cancer cells. All the test compounds increased the intracellular accumulation rate of rhodamine 123 in MDR cells (Bel7402 and HCT8), and most exhibited more potent MDR-reversing activity relative to the reference compound verapamil. Compounds 8, 10, 13, and 14 enhanced intracellular accumulation of doxorubicin in Bel7402 and HCT8 cells.
查看更多